More on MYGN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.63 |
|
|||
| Open | $4.63 | ||||
| 52 Wk High | $45.34 | ||||
| 52 Wk Low | $15.92 | ||||
| Day High | $4.63 | ||||
| Day Low | $4.63 | ||||
| P/E | 1.99 | ||||
| EPS | $2.33 | ||||
| Volume | 21 | ||||
- Form 4 MYRIAD GENETICS INC For: Jun 23 Filed by: Skovronsky Daniel
- Myriad Genetics expands Precise MRD cancer test to three tumor types
- Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
- Myriad Genetics board member Skovronsky resigns
- Form 8-K MYRIAD GENETICS INC For: Jun 17
- Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Raha Samraat S.
- Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Donnelly Brian J
- TD Cowen notes short interest shifts in life science tools stocks
- Form 4 MYRIAD GENETICS INC For: Jun 08 Filed by: Kumar Rashmi
- Form 144 MYRIAD GENETICS INC Filed by: Kumar Rashmi
Entities mentioned with MYGN
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
